Xeris Pharmaceuticals | 销售成本

Cost Of Sales 更改 日
Adcock Ingram Holdings ZAR 2.91B 127.52M 2023-06
Celltrion KRW 73.04B 168.39B 2024-03
Cspc Pharmaceutical CNY 2.2B 107.66M 2023-12
Ecofibre AUD 1.28M 6.12M 2023-06
Eli Lilly USD 1.67B 114.5M 2024-03
Kangmei Pharma CNY 1.03B 53.55M 2024-03
Knight Therapeutics CAD 44.9M 4.92M 2024-03
Laboratorios Farma EUR 65.5M 108.34M 2024-03
Malin Corporation EUR 15.4M 0 2020-12
Medical Developments International AUD 6.09M 2.05M 2023-06
Organigram Holdings CAD 28.03M 10.84M 2024-03
Pacira USD 47.42M 276K 2024-03
Perrigo USD 724.4M 5.2M 2024-03
Pharma Mar EUR 1.76M 685K 2024-03
Probiotec AUD 74.79M 109.35K 2023-06
Qiagen NV USD 167.81M 25.26M 2024-03
Sartorius EUR 423.4M 95.3M 2024-03
Sino Biopharmaceutical CNY 3.26B 420.59M 2023-06
Supernus Pharmaceuticals USD 16.31M 3.32M 2024-03
Tilray USD 138.94M 7.42M 2024-02
Zz Pientze Pharmaceu 1.25B 64.01M 2023-09



Xeris Pharmaceuticals 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.